Discussion about this post

User's avatar
Nick Kottenstette's avatar

This is a good question. The vaccinated immune system may never develope a sufficient number of mucosal antibodies to rid the virus due to OAS.

Being jab free for over ten years now, I can say that I have not had to deal with a sinus infection for years and they were a chronic problem for me in the past.

Expand full comment
Janis's avatar

Thank you for paying attention to NALT immunity in the URT. Please publish some posts about intramuscular vaccine induced Abs, T cells in the URT with particular focus to neutralizing capacity and half-life of vaccine induced immune cells there. Enlightening topic for the C19 pandemic.

With regard to the present post I have the following remarks:

- Nasal sinuses are not immunoprivileged tissues of mammalians. Typical immunoprivileged tissues of mammalians include the pregnant uterus, eye, brain, and testis. Therefore, virus does not hide there, while the viral particles may remain there for prolonged period of time;

- Even seroconverted individuals may get reinfected when exposed to high loads of pathogen. Without sanitation plagues would not have been stopped in Middle Ages. High viral loads of SARS-CoV-2 is hard to reduce without nasal/oral hygiene and ventilation while the virus can easily reside in multiple reservoirs: pets and livestock, for instance.

- Omicron BA.5 have managed to develop reliance on multiple cell surface proteins to ensure membrane fusion. While Delta was primary dependent on TMPRSS2, BA.5 uses C-type lectin, Adam10 or 17, etc, therefore BA.5 tissue tropisms is not limited to ACE2 dominant cell lines. This is serious concern that prolonged sub-optimal immune pressure may push the virus to immunoprivileged tissues. And with the respiratory virus only BBB protects brains from this risk.

Expand full comment
22 more comments...

No posts